Temozolomide-d3

CAT:
804-HY-17364S
Size:
1 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Temozolomide-d3 - image 1

Temozolomide-d3

  • Description:

    Temozolomide-d3 is the deuterium labeled Temozolomide. Temozolomide (NSC 362856) is an oral active DNA alkylating agent that crosses the blood-brain barrier. Temozolomide is also a proautophagic and proapoptotic agent. Temozolomide is effective against tumor cells that are characterized by low levels of O6-alkylguanine DNA alkyltransferase (OGAT) and a functional mismatch repair system. Temozolomide has antitumor and antiangiogenic effects[1][2].
  • UNSPSC:

    12352005
  • Hazard Statement:

    H302, H340, H350, H360, H412
  • Target:

    Apoptosis; Autophagy; DNA Alkylator/Crosslinker
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    Apoptosis; Autophagy; Cell Cycle/DNA Damage
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Cancer
  • Purity:

    99.87
  • Solubility:

    10 mM in DMSO|DMF : ≥ 5mg/mL|DMSO : ≥ 5mg/mL
  • Smiles:

    O=C (N1C=N2) N (N=NC1=C2C (N) =O) C ([2H]) ([2H]) [2H]
  • Molecular Formula:

    C6H3D3N6O2
  • Molecular Weight:

    197.17
  • Precautions:

    H302, H340, H350, H360, H412
  • References & Citations:

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Tentori L, et al. Combined treatment with temozolomide and poly (ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site. Blood. 2002 Mar 15;99 (6) :2241-4.|[3]Perazzoli G, et al. Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression. PLoS One. 2015 Oct 8;10 (10) :e0140131.|[4]Mathieu V, et al. Combining Anti-Human VEGF with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model. Neoplasia. 2008 Dec;10 (12) :1383-92.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -20°C, 3 years (Powder)
  • Scientific Category:

    Isotope-Labeled Compounds
  • Clinical Information:

    No Development Reported
  • CAS Number:

    208107-14-6